BiotechTube
Home/LinkGevity/Serena Kern-Libera
SK

Serena Kern-Libera

Chief Operating Officer

LinkGevity

Therapeutic Areas

AgingKidney DiseaseInflammatory Bowel DiseaseOncology

LinkGevity Pipeline

DrugIndicationPhase
LINK-001Kidney Disease (Acute Kidney Injury)Phase 2
LINKAgingPhase 2
Anti-Necrotics PlatformVarious (Tissue Engineering, Organ Preservation)Non-Clinical

Leadership Team at LinkGevity

DC
Dr. Carina Kern
Chief Executive Officer
GJ
Greg Jarzabek
Chief Financial Officer
LR
Lukasz Rzeczkowski
Chief Commercial Officer
NG
Nikodem Grzesiak
Chief Technology Officer
BD
Bill Davis
Chief R&D Officer
RL
Rafal Libera
Chief Growth Officer
View full LinkGevity profile